BMS-919373 is a Potassium channel Kv1.5 (KCNA5) inhibitor for use in atrial fibrillation and acute coronary syndromes. Phase II development is underway in the US and Canada for paroxysmal atrial fibrillation.
纯度：≥98%
CAS：1272353-82-8
m.cnreagent.com
